Canvas & Ratio
Choose your destination platform format
Layout Template
Choose a content structure for your slides
Preset Themes
Typography & Sizing
Brand Kit Customization
AGENCYConfigure brand assets for headers & footers
Outro Slide CTA
Customize your closing call-to-action slide
Background Pattern
Build Your Carousel
Drag and drop any post card below onto a slide, or use the quick buttons to insert content/images instantly!
Turns out I was featured in this very dumb article about long covid. And the guy lives in my small town and didnāt even reach out to ask for my perspective! Just sent him this email. <a target="_blank" href="https://twitter.com/AlanLevinovitz/status/2061503084438712346" color="blue">x.com/AlanLevinovitzā¦</a>
Your name was redacted in the email I received, by the researcher, because itās unethical to share the name. I didnāt choose not to reach out to you ā I didnāt find out it was you until just now, when you emailed me.
What was the HIIT protocol? HIIT is such a broad category in exercise science unfortunately. If it was a threshold or CV or similarly aerobic based interval session it could have been appropriate.
I don't see the research protocol online anymore. But any sort of exercise protocol would have required screening for those who suffer from post exertional malaise and communication of potential riskā neither of which were included.
Megan, you really don't know what you are talking about. First of all, they DID disclose serious risks like risk of death from exercise, as all cardiopulmonary trials do. These are people who do rehab with severe heart failure patients and cancer chemo patients. I'm not sure you even had access to approved protocols or consent forms ā as I recall, they told me all you could see was their trial registration ā but if you did, you would know that, and if you didn't, then here we are. As for screening people for PEM: as I lay out, at length in the article, there is no good way to "screen" for PEM. Self-report doesn't align well with what happens in clinical trials, so if you screen people using self-report, your trial will build in exactly the kind of problems with patient population that I describe. You can't screen people using self-report, and then tell them about the risks associated with what they are self-reporting, when neither the self-report nor the risks are established as reliable in the first place! I don't know what else to tell you. You have accused me, both online and by email, of being misinformed and not in my area of expertise. This reply and your correspondence with me indicates the reverse.